← Open Payments lookup

ELIZABETH MCCUSKER-HUNT: Open Payments

NPI 1770597429 · AMESBURY, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,756 in 78 payments from 11 companies in 2025. Trend: 2023 $1,612 · 2024 $1,497 · 2025 $1,756

Food & beverage: $1,644Education: $111
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)16$412
E.R. Squibb & Sons, L.L.C.16$386
Alkermes, Inc.12$246
ABBVIE INC.12$226
Teva Pharmaceuticals USA, Inc.10$219
Neurocrine BioSciences, Inc.2$68
Vanda Pharmaceuticals Inc.4$65
Axsome Therapeutics, Inc.2$58
Otsuka America Pharmaceutical, Inc.2$46
Takeda Pharmaceuticals U.S.A., Inc.1$15

Products named: CAPLYTA, COBENFY, VRAYLAR, ARISTADA, LYBALVI, INGREZZA, FANAPT, REXULTI.

Industry payments across MA — which companies pay providers there.